Publicacións (36) Publicacións nas que participase algún/ha investigador/a

2013

  1. A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer

    BMC Genomics, Vol. 14

  2. Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: Results from a randomized, phase II prospective trial

    Annals of Oncology, Vol. 24, Núm. 2, pp. 448-453

  3. Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases

    PLoS ONE, Vol. 8, Núm. 7

  4. Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer

    Journal of Geriatric Oncology, Vol. 4, Núm. 2, pp. 114-121

  5. Black-pigmented sputum

    Journal of Cytology, Vol. 30, Núm. 4, pp. 274-275

  6. C-terminal-PEDF reduces IC50 doses and chemoresistant population of CD133 and BCRP1-positve cancer stem like cells

    Journal of Analytical Oncology, Vol. 2, Núm. 4, pp. 195-208

  7. Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis

    PLoS ONE, Vol. 8, Núm. 1

  8. Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

    Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 425-433

  9. Consenso en cáncer hereditario entre la Sociedad Española de Oncología Médica y las sociedades de atención primaria

    Semergen: revista española de medicina de familia, Núm. 5, pp. 259-266

  10. Cáncer de pulmón en el área sanitaria de Pontevedra: incidencia, presentación clínica y supervivencia

    Anales del sistema sanitario de Navarra, Vol. 36, Núm. 2, pp. 217-227

  11. Dolor como factor predictor de depresión en el paciente oncológico: estudio de casos y controles. Estudio D-PRESS

    Revista de la Sociedad Espanola del Dolor, Vol. 20, Núm. 3, pp. 113-121

  12. E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis

    Oncogene, Vol. 32, Núm. 24, pp. 2937-2951

  13. FX enzyme and GDP-L-Fuc transporter expression in colorectal cancer

    Histopathology, Vol. 63, Núm. 2, pp. 174-186

  14. Gemcitabine and capecitabine as third- or later-line therapy for refractory advanced colorectal cancer: A retrospective study

    Anticancer Research, Vol. 33, Núm. 9, pp. 4089-4096

  15. Genetic study confirms association of HLA-DPA1*01:03 subtype with ankylosing spondylitis in HLA-B27-positive populations

    Human Immunology, Vol. 74, Núm. 6, pp. 764-767

  16. Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation

    Blood, Vol. 121, Núm. 10, pp. 1769-1782

  17. Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease

    NeuroMolecular Medicine, Vol. 15, Núm. 2, pp. 295-309

  18. Management of thrombosis with bevacizumab in metastatic colorectal cancer

    Cancer and Chemotherapy Reviews, Vol. 8, Núm. 2, pp. 56-62

  19. Mesotelioma peritoneal maligno con afectación uterina

    Progresos de Obstetricia y Ginecologia, Vol. 56, Núm. 8, pp. 414-417

  20. Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: A pooled analysis

    Breast Cancer Research, Vol. 15, Núm. 6